Results 111 to 120 of about 162,220 (306)
Rapid Volume Expansion in Patients with Interstitial Lung Diseases
Graziano C. Carlon+5 more
openalex +1 more source
The clinical manifestations of the five cases of lymphangitic carci-nomatosis of the lung presented as diffuse and interstitial disease . [PDF]
Young Joo Sung+4 more
openalex +1 more source
This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in 69 patients who underwent R0 salvage surgery for esophageal squamous cell carcinoma. Of note, abdominal LN metastases had a negative impact on survival in our series.
Kotaro Sugawara+9 more
wiley +1 more source
Patient-centered care in pulmonary fibrosis: access, anticipate, and act
Comprehensive care integrates individual patient needs and is highly valued for patients with pulmonary fibrosis (PF). The importance of a patient-centered care approach is rooted in the unpredictable progressiveness of the disease course in PF.
Delian E. Hofman+5 more
doaj +1 more source
ImportanceInterstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. In the US, ILD affects approximately 650 000 people and causes approximately 25 000 to 30 000 deaths per ...
openaire +3 more sources
Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang+6 more
wiley +1 more source
This work describes a biomimetic extracellular vesicle‐spherical nucleic acid (BEV‐SNA) platform for idiopathic pulmonary fibrosis (IPF) therapy. BEV‐SNA is composed of mechanically extruded BEVs from primary MSCs and cholesterol‐modified ssDNA that are assembled through hydrophobic interactions.
Saiyun Lou+11 more
wiley +1 more source
Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
Sachin Chaudhary+4 more
doaj +1 more source
Oxidized BAL fluid proteins in patients with interstitial lung diseases [PDF]
Anke‐Gabriele Lenz+2 more
openalex +1 more source
AI‐Driven Microphysiological Systems for Advancing Nanoparticle Therapeutics
This review outlines recent advances in integrating artificial intelligence with microphysiological systems for nanoparticle evaluation. It highlights data‐driven optimization, image‐based prediction, and AI‐enabled analysis frameworks that advance translational research and support the development of personalized nanomedicine. Nanoparticles (NPs) play
Yedam Lee+3 more
wiley +1 more source